Development Level

Tbio 3 | 10,625
Tdark 1 | 7,003

Disease

atypical teratoid / rhabdoid tumor 3 | 4,369
glioblastoma 3 | 5,572
adult high grade glioma 2 | 2,148
ependymoma 2 | 2,514
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
lung carcinoma 2 | 2,844
medulloblastoma 2 | 1,524
medulloblastoma, large-cell 2 | 6,234
osteosarcoma 2 | 7,933
ovarian cancer 2 | 8,484
pilocytic astrocytoma 2 | 3,086
primitive neuroectodermal tumor 2 | 3,031
psoriasis 2 | 6,685
Adenoid Cystic Carcinoma 1 | 99
Adenoma 1 | 165
Animal Mammary Neoplasms 1 | 136
Bladder Neoplasm 1 | 109
Breast cancer 1 | 3,094
Cancer 1 | 2,346
Carcinoma 1 | 2,147
Carcinoma, Lobular 1 | 3
Cardiac arrest 1 | 26
Colorectal Cancer 1 | 47
Colorectal Neoplasms 1 | 217
Disease Progression 1 | 125
Endometrial Neoplasms 1 | 50
Endometrial carcinoma 1 | 18
Endometriosis 1 | 535
GASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFT PALATE 1 | 1
Gastritis 1 | 44
Gaucher disease type 1 1 | 171
Helicobacter Infections 1 | 5
Hereditary Diffuse Gastric Cancer 1 | 3
Inflammatory bowel disease 1 | 142
Intestinal benign neoplasm 1 | 11
Invasive Ductal Breast Carcinoma 1 | 9
Kidney disease 1 | 396
Listeriosis 1 | 17
Liver Neoplasms, Experimental 1 | 48
Lobular neoplasia 1 | 15
Lung disease 1 | 132
Mammary Neoplasms 1 | 410
Mammary Neoplasms, Experimental 1 | 150
Mesothelioma 1 | 40
Mycoplasma Infections 1 | 3
Neoplasm Invasiveness 1 | 127
Neoplasm Metastasis 1 | 138
Neoplastic Cell Transformation 1 | 81
Neoplastic Syndromes, Hereditary 1 | 48
Nerve Degeneration 1 | 73
Osteoporosis 1 | 257
Pancreatic Neoplasm 1 | 79
Pick disease 1 | 1,893
Precancerous Conditions 1 | 69
Prostate cancer 1 | 172
Prostate cancer, familial 1 | 13
Prostatic Intraepithelial Neoplasias 1 | 11
Prostatic Neoplasms 1 | 471
Salivary Gland Neoplasms 1 | 45
Squamous cell carcinoma 1 | 94
Stomach Neoplasms 1 | 282
Ureteral disease 1 | 23
acute quadriplegic myopathy 1 | 1,157
adrenocortical carcinoma 1 | 1,427
astrocytic glioma 1 | 2,241
diabetes mellitus 1 | 1,663
ductal carcinoma in situ 1 | 1,745
group 4 medulloblastoma 1 | 1,875
interstitial cystitis 1 | 2,299
interstitial lung disease 1 | 291
invasive ductal carcinoma 1 | 2,950
juvenile dermatomyositis 1 | 1,189
malignant mesothelioma 1 | 3,162
mucosa-associated lymphoid tissue lymphoma 1 | 480
non diabetic and post-ischemic heart failure 1 | 200
non primary Sjogren syndrome sicca 1 | 840
non-small cell lung cancer 1 | 2,798
non-small cell lung carcinoma 1 | 413
oligodendroglioma 1 | 2,849
ovarian neoplasm 1 | 97
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Enzyme 2 | 4,146
Non-IDG 1 | 11,971
Transporter 1 | 473

Grant Application

1R21AI083991-01 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Anaphase-promoting complex subunit 5 ANAPC5 Tbio Enzyme -1.42977 27.2 218
Anaphase-promoting complex subunit 1 ANAPC1 Tbio Enzyme -1.49520 32.5 404
Cadherin-1 CDH1 Tbio Non-IDG -3.78431 5832.3 1347
Solute carrier family 25 member 41 SLC25A41 Tdark Transporter 0.23 0.38 8